FOXP3 and heart failure: In a study of mouse models with heart failure, CD4+ Foxp3+ Tregs were found to expand robustly in the heart and circulation for adverse cardiac remodeling, resulting in the suppression of circulating CD4+ T cells and systemic inflammation (14).